Nitric oxide-independent inhibition by sodium nitroprusside of the native N-methyl-D-aspartate recognition domain in a manner different from that by potassium ferrocyanide

Neurochemistry International

Volumn 33, Issue 1, 1998, Pages 1-9

  Ogita, K ^a   Shuto, M ^a   Yoneda, Y ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; 5,7 DICHLOROKYNURENIC ACID; DITHIOTHREITOL; DIZOCILPINE; FERROCYANIDE; GLYCINE; N ACETYL S NITROSOPENICILLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM FERRICYANIDE; S NITROSOGLUTATHIONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; RAT; SYNAPTIC MEMBRANE;

ANIMALIA;

EID: 0032103989     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(05)80002-6     Document Type: Article

References (37)

1. Corasaniti M.T., Tartaglia R.L., Melino G., Nistico G., Finazzi-Agro A. Neurosci. Lett. 147:1992;221-223.
2. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Proc. natn. Acad. Sci. U.S.A. 88:1991;6368-6371.
3. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. J. Neurosci. 13:1993;2651-2661.
4. Demerle-Pallardy C., Lonchampt M.-O., Chabrier P.-E., Braquet P. Biochem. biophys. Res. Commun. 181:1991;456-464.
5. Enomoto R., Ogita K., Han D., Yoneda Y. J. Neurochem. 59:1992;473-481.
6. Fujimori H., Hou P.H. Brain Res. 554:1991;355-357.
7. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Brain Res. 625:1993;337-341.
8. Hollmann M., Heinemann S. Ann. Rev. Neurosci. 23:1994;31-108.
9. Izumi Y., Benz A.M., Clifford D.B., Zorumski C.F. Neurosci. Lett. 35:1992;227-230.
10. Kiedrowski L., Manev H., Costa E., Wroblewski J.T. Neuropharmac. 30:1991;1241-1243.
11. Kiedrowski L., Costa E., Wroblewski J.T. Molec. Pharmac. 41:1992;779-784.
12. Lei S.Z., Pan Z.-H., Aggarwal S.K., Chen H.-S.V., Hartman J., Sucher N.J., Lipton S.A. Neuron. 8:1992;1087-1099.
13. Lerner-Natoli M., Rondouin G., Debock F., Bockaert J. NeuroReport. 3:1992;1109-1112.
14. Lipton S.A., Stamler J.S. Neuropharmac. 33:1994;1229-1233.
15. Lipton S.A., Choi Y.-B., Pan Z.-H., Lei S.Z., Stamler J.S. Nature. 364:1993;626-632.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. biol. Chem. 193:1951;265-275.
17. Nakanishi S., Masu M. Ann.Rev. Biophys. Biomol. Struct. 23:1994;319-348.
18. Ogita K., Yoneda Y. Biochem. biophys. Res. Commun. 153:1988;510-517.
19. Ogita K., Kouda T., Suzuki T., Ohkawara A., Enomoto R., Nabeshima T., Yoneda Y. Neurochem.Int. 18:1991;55-62.
20. Ogita K., Sakamoto T., Han Da, Azuma Y., Yoneda Y. Neurochem. Int. 24:1994;379-388.
21. Ogita K., Suzuki T., Yoneda Y. Neuropharmac. 28:1989;1263-1270.
22. Ogita K., Suzuki T., Zuo P., Yoneda Y. J. Neurochem. 59:1992;1008-1016.
23. Oh S., McCaslin P.P. Neurochem. Res. 20:1995;779-784.
24. Pauwels P.J., Leysen J.E. Neurosci. Lett. 143:1992;27-30.
25. Seeburg P.H. Neuroscience. 16:1993;359-365.
26. Shuto M., Ogita K., Yoneda Y. Neurochem. Int. 31:1997;73-82.
27. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., Nathan C.F. FASEB J. 5:1991;98-103.
28. Suzuki T., Ogita K., Yoneda Y. Neurochem. Int. 23:1993;427-440.
29. Williams K. Molec. Pharmac. 46:1994;161-168.
30. Williams K., Zappia A.M., Pritchett D.B., Shen Y.M., Molinoff P.B. Molec. Pharmac. 45:1994;803-809.
31. Yoneda Y., Ogita K. Analyt. Biochem. 177:1989;250-255.
32. Yoneda Y., Ogita K. J. Pharmac. exp. Ther. 259:1991;86-96.
33. Yoneda Y., Ogita K., Enomoto R. J.Pharmac. exp. Ther. 256:1991;1161-1172.
34. Yoneda Y., Suzuki T., Ogita K., Han D. J. Neurochem. 60:1993;634-654.
35. Yu O., Chuang D.-M. J. Neurochem. 66:1996;346-354.
36. Zuo P., Ogita K., Han D., Yoneda Y. Brain Res. 609:1993;253-261.
37. Zuo P., Ogita K., Suzuki T., Han D., Yoneda Y. J. Neurochem. 61:1993;1865-1873.